Delfi Diagnostics, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Delfi Diagnostics, Inc.
IV BioHoldings CEO Marty Keiser connects data, technology, capital and people to create start-ups focusing on liquid biopsy programs.
Deal-making and financing activities are on the rise for liquid biopsy diagnostic products in 2021 despite questions remaining around whether the technology can unseat standard-of-care biomarker and imaging tests.
- In Vitro Diagnostics
- Laboratory Testing Services
In Vitro Diagnostics
- Hematology, Coagulation
- Molecular Diagnostics & Genetic Testing